Emodin reverses gemcitabine resistance in pancreatic cancer cells via the mitochondrial apoptosis pathway in vitro

Gemcitabine resistance is a common problem of pancreatic cancer chemotherapy, and how to reverse it plays an important role in the treatment of pancreatic cancer. This study investigated the effect of emodin on the gemcitabine-resistant pancreatic cancer cell line SW1990/Gem, and explored the potent...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: LIU, DIAN-LEI, BU, HEQI, LI, HONG, CHEN, HUI, GUO, HONG-CHUN, WANG, ZHAO-HONG, TONG, HONG-FEI, NI, ZHONG-LIN, LIU, HAI-BIN, LIN, SHENG-ZHANG
Formato: Artigo
Idioma:Inglês
Publicado: D.A. Spandidos 2011
Assuntos:
Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3584653/
https://ncbi.nlm.nih.gov/pubmed/22159556
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2011.1285
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares